NCT06781021

Brief Summary

Study Objective: The study aims to determine if tranexamic acid (TXA) is as effective as a tourniquet in improving visual clarity during arthroscopic ACL reconstruction surgery. Study Design: This is a randomized prospective controlled trial involving patients with complete ACL tears. Participants will be randomly assigned to either receive TXA or undergo surgery with a tourniquet. Data Collection: The study will use questionnaires and scales to assess the effects of TXA on visual clarity. Data will be stored securely and analyzed using the SPSS system. Ethical Considerations: Ethical guidelines will be strictly followed, including informed consent, confidentiality, and the right to withdraw from the study at any time without affecting the standard of care. Expected Outcome: The study aims to provide insights into the efficacy of TXA in improving surgical visibility, potentially influencing future protocols in arthroscopic surgeries. Results will be disseminated through academic presentations and publications.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2024

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

November 19, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 17, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

January 17, 2025

Status Verified

October 1, 2024

Enrollment Period

1 year

First QC Date

November 19, 2024

Last Update Submit

January 16, 2025

Conditions

Keywords

ACL Tear

Outcome Measures

Primary Outcomes (3)

  • Grading TXA

    The grading allotted to patients treated with tranexamic acid assed by the Arthroscopic visual clarity scale.

    The questionnaire will be administered to the surgeon right after surgery is completed.

  • Grading Tourniquet

    The Grading given to patients treated with Pneumatic torniquet assessed by the Arthroscopic Visual clarity scale

    The questionnaire will be administered to the surgeon right after surgery is completed.

  • Grading Tourniquet vs TXA

    The grading given to patients treated with TXA vs Pneumatic torniquet assessed by the arthroscopic visual clarity scale

    The questionnaire will be administered to the surgeon right after surgery is completed.

Study Arms (2)

Tourniquet Surgery

ACTIVE COMPARATOR

Torniquet surgery prevents blood loss by acting as a physical barrier to cut vessels and tissue. This physical barrier is in the form of pressure which is applied to the vessels but also to the surrounding tissues it touches. This pressure can damage nerves, muscle which can delay return to normal function afterwards if applied for a prolonged period. This however has not been a common occurrence and is used as the standard of care in ACL arthroscopic surgeries.

Procedure: TourniquetProcedure: TXA

TXA Surgery

ACTIVE COMPARATOR

TXA does the has the same function without the physical compression. In other words, it acts as a chemical torniquet. It enables clotting at damaged tissue which are more likely to bleed and obstruct the surgical field. This drug has not been shown to have any adverse reactions and is safe for use.

Procedure: TourniquetProcedure: TXA

Interventions

TourniquetPROCEDURE

In all cases the application of a pneumatic torniquet will be applied to the proximal thigh after induction of anesthesia but will not be inflated for the group receiving TXA.

TXA SurgeryTourniquet Surgery
TXAPROCEDURE

In all cases the application of a pneumatic torniquet will be applied to the proximal thigh after induction of anesthesia but will not be inflated for the group receiving TXA.

TXA SurgeryTourniquet Surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients with complete ACL tears requiring reconstruction for the first time.
  • Ages \>18

You may not qualify if:

  • Dementia or any patient with cognitive impairment.
  • Patients with previous functional disabilities (Patients with functional disabilities affecting the lower limb such as stroke, neuromuscular disorders or any pathology limiting Knee range of motion can cause abnormalities within the joint enabling scaring, fibrosis or even hypoplastic degenerating tissue. These features may alter the vascularity and directly affect visual clarity)
  • Bleed disorders or coagulopathies.
  • Sickle Cell Disease, liver, or renal failure.
  • Multi- ligamentous knee injuries.
  • Anticoagulant therapy.
  • Revision ACL reconstruction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of the West Indies, Department of Surgery

Kingston, Jamaica, Jamaica

Location

Related Publications (38)

  • Choudhary A, Kanodia N, Agrawal S, Bhasin VB, Singh A. Tourniquet Use in Arthroscopic ACL Reconstruction: A Blinded Randomized Trial. Indian J Orthop. 2020 Sep 12;55(2):384-391. doi: 10.1007/s43465-020-00250-z. eCollection 2021 Apr.

    PMID: 33927817BACKGROUND
  • Ockerman A, Vanassche T, Garip M, Vandenbriele C, Engelen MM, Martens J, Politis C, Jacobs R, Verhamme P. Tranexamic acid for the prevention and treatment of bleeding in surgery, trauma and bleeding disorders: a narrative review. Thromb J. 2021 Aug 11;19(1):54. doi: 10.1186/s12959-021-00303-9.

    PMID: 34380507BACKGROUND
  • Hoogeslag RA, Brouwer RW, van Raay JJ. The value of tourniquet use for visibility during arthroscopy of the knee: a double-blind, randomized controlled trial. Arthroscopy. 2010 Sep;26(9 Suppl):S67-72. doi: 10.1016/j.arthro.2009.12.008. Epub 2010 May 13.

    PMID: 20810094BACKGROUND
  • Smith TO, Hing CB. A meta-analysis of tourniquet assisted arthroscopic knee surgery. Knee. 2009 Oct;16(5):317-21. doi: 10.1016/j.knee.2009.01.004. Epub 2009 Feb 23.

    PMID: 19239987BACKGROUND
  • Stefan AM, Gronau QF, Schonbrodt FD, Wagenmakers EJ. A tutorial on Bayes Factor Design Analysis using an informed prior. Behav Res Methods. 2019 Jun;51(3):1042-1058. doi: 10.3758/s13428-018-01189-8.

    PMID: 30719688BACKGROUND
  • Robert C, Chopin N, Rousseau J, Bernardo J, Gelman A, Kass R, et al. Harold Jeffreys's Theory of Probability Revisited. 2008.

    BACKGROUND
  • Vargha A, Delaney H. A Critique and Improvement of the "CL" Common Language Effect Size Statistics of McGraw and Wong. Journal of Educational and Behavioral Statistics - J EDUC BEHAV STAT. 2000;25.

    BACKGROUND
  • Aziz Catalttepe KO. The effect of a single dose of intravenous tranexamic acid on visual clarity in knee arthroscopic meniscectomy without a tourniquet

    BACKGROUND
  • Patel NK, Johns W, Vedi V, Langstaff RJ, Golladay GJ. Tourniquet and tranexamic acid use in total knee arthroplasty. Arthroplast Today. 2020 Apr 28;6(2):246-250. doi: 10.1016/j.artd.2020.02.007. eCollection 2020 Jun.

    PMID: 32577472BACKGROUND
  • Jennings JD, Solarz MK, Haydel C. Application of Tranexamic Acid in Trauma and Orthopedic Surgery. Orthop Clin North Am. 2016 Jan;47(1):137-43. doi: 10.1016/j.ocl.2015.08.014.

    PMID: 26614928BACKGROUND
  • Hofmann A, Ozawa S, Farrugia A, Farmer SL, Shander A. Economic considerations on transfusion medicine and patient blood management. Best Pract Res Clin Anaesthesiol. 2013 Mar;27(1):59-68. doi: 10.1016/j.bpa.2013.02.001.

    PMID: 23590916BACKGROUND
  • Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med. 2008 Sep;36(9):2667-74. doi: 10.1097/CCM.0b013e3181844677.

    PMID: 18679112BACKGROUND
  • Zollo RA, Eaton MP, Karcz M, Pasternak R, Glance LG. Blood transfusion in the perioperative period. Best Pract Res Clin Anaesthesiol. 2012 Dec;26(4):475-84. doi: 10.1016/j.bpa.2012.10.001.

    PMID: 23351234BACKGROUND
  • Han C, Liu M, Lian X, Sun T, Yan S, Bai X, Gan D, Leng B, Qiu Y, Ren Y. Tranexamic acid use in arthroscopic rotator cuff repair is an effective and safe adjunct to improve visualization: a systematic review and meta-analysis. J Shoulder Elbow Surg. 2023 Nov;32(11):2389-2399. doi: 10.1016/j.jse.2023.06.013. Epub 2023 Jul 17.

    PMID: 37468032BACKGROUND
  • Kawaguchi S, Fukuta S, Kano M, Sairyo K. Reduction of perioperative blood loss and operating time for arthroscopic rotator cuff repair by intravenous administration of tranexamic acid. Asia Pac J Sports Med Arthrosc Rehabil Technol. 2023 Feb 7;31:6-10. doi: 10.1016/j.asmart.2023.01.001. eCollection 2023 Jan.

    PMID: 36820053BACKGROUND
  • Ersin M, Demirel M, Buget MI, Edipoglu IS, Atalar AC, Ersen A. The effect of intravenous tranexamic acid on visual clarity during arthroscopic rotator cuff repair: A randomized, double-blinded, placebo-controlled pilot study. Acta Orthop Traumatol Turc. 2020 Nov;54(6):572-576. doi: 10.5152/j.aott.2020.19164.

    PMID: 33423986BACKGROUND
  • Liu YF, Hong CK, Hsu KL, Kuan FC, Chen Y, Yeh ML, Su WR. Intravenous Administration of Tranexamic Acid Significantly Improved Clarity of the Visual Field in Arthroscopic Shoulder Surgery. A Prospective, Double-Blind, and Randomized Controlled Trial. Arthroscopy. 2020 Mar;36(3):640-647. doi: 10.1016/j.arthro.2019.10.020. Epub 2019 Dec 20.

    PMID: 31870749BACKGROUND
  • Dugani S, Wasan KM, Kissoon N. World Health Organization and Essential Medicines. J Pharm Sci. 2018 May;107(5):1261-1262. doi: 10.1016/j.xphs.2017.12.019. Epub 2017 Dec 24.

    PMID: 29277641BACKGROUND
  • Haratian A, Shelby T, Hasan LK, Bolia IK, Weber AE, Petrigliano FA. Utilization of Tranexamic Acid in Surgical Orthopaedic Practice: Indications and Current Considerations. Orthop Res Rev. 2021 Oct 19;13:187-199. doi: 10.2147/ORR.S321881. eCollection 2021.

    PMID: 34703327BACKGROUND
  • Pabinger I, Fries D, Schochl H, Streif W, Toller W. Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis. Wien Klin Wochenschr. 2017 May;129(9-10):303-316. doi: 10.1007/s00508-017-1194-y. Epub 2017 Apr 21.

    PMID: 28432428BACKGROUND
  • Hao S, Li H, Liu S, Meng S, Zhang X, Wang L, Yang H, Zhang L, Dong S. The effect of intravenous unit-dose tranexamic acid on visible and hidden blood loss in posterior lumbar interbody fusion: a randomized clinical trial. Sci Rep. 2023 Mar 22;13(1):4714. doi: 10.1038/s41598-022-27307-3.

    PMID: 36949108BACKGROUND
  • Vrontis K, Tsinaslanidis G, Drosos GI, Tzatzairis T. Perioperative Blood Management Strategies for Patients Undergoing Total Hip Arthroplasty: Where Do We Currently Stand on This Matter? Arch Bone Jt Surg. 2020 Nov;8(6):646-655. doi: 10.22038/abjs.2020.45651.2249.

    PMID: 33313343BACKGROUND
  • Picetti R, Shakur-Still H, Medcalf RL, Standing JF, Roberts I. What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies. Blood Coagul Fibrinolysis. 2019 Jan;30(1):1-10. doi: 10.1097/MBC.0000000000000789.

    PMID: 30585835BACKGROUND
  • Yaghmour KM, Al-Khateeb H. Anterior cruciate ligament reconstruction without the use of a tourniquet. Ann R Coll Surg Engl. 2019 Feb;101(2):123-125. doi: 10.1308/rcsann.2018.0197. Epub 2018 Nov 1.

    PMID: 30381954BACKGROUND
  • Carter KB, Shaw A, Telfer AB. Tourniquets for surgery: safety aspects. J Med Eng Technol. 1983 May-Jun;7(3):136-9. doi: 10.3109/03091908309032577.

    PMID: 6876134BACKGROUND
  • Liu D, Graham D, Gillies K, Gillies RM. Effects of tourniquet use on quadriceps function and pain in total knee arthroplasty. Knee Surg Relat Res. 2014 Dec;26(4):207-13. doi: 10.5792/ksrr.2014.26.4.207. Epub 2014 Dec 2.

    PMID: 25505702BACKGROUND
  • Masri BA, Eisen A, Duncan CP, McEwen JA. Tourniquet-induced nerve compression injuries are caused by high pressure levels and gradients - a review of the evidence to guide safe surgical, pre-hospital and blood flow restriction usage. BMC Biomed Eng. 2020 May 28;2:7. doi: 10.1186/s42490-020-00041-5. eCollection 2020.

    PMID: 32903342BACKGROUND
  • Atisuksma ID, Rhatomy S, Dewo P. A tourniquet-less technique using saline epinephrine irrigation system in an arthroscopic ACL reconstruction in patient with history of popliteal artery ligation. Int J Surg Case Rep. 2018;53:157-162. doi: 10.1016/j.ijscr.2018.10.040. Epub 2018 Nov 1.

    PMID: 30396128BACKGROUND
  • Derriks JHG, Hilgersom NFJ, Middelkoop E, Samuelsson K, van den Bekerom MPJ. Electrocautery in arthroscopic surgery: intra-articular fluid temperatures above 43 degrees C cause potential tissue damage. Knee Surg Sports Traumatol Arthrosc. 2020 Jul;28(7):2270-2278. doi: 10.1007/s00167-019-05574-4. Epub 2019 Jun 27.

    PMID: 31250052BACKGROUND
  • Olszewski AD, Jones R, Farrell R, Kaylor K. The effects of dilute epinephrine saline irrigation on the need for tourniquet use in routine arthroscopic knee surgery. Am J Sports Med. 1999 May-Jun;27(3):354-6. doi: 10.1177/03635465990270031501.

    PMID: 10352773BACKGROUND
  • Hsiao MS, Kusnezov N, Sieg RN, Owens BD, Herzog JP. Use of an Irrigation Pump System in Arthroscopic Procedures. Orthopedics. 2016 May 1;39(3):e474-8. doi: 10.3928/01477447-20160427-01. Epub 2016 May 2.

    PMID: 27135450BACKGROUND
  • Li S, A L. The hidden blood loss and its factors in patients undergoing minimally invasive knee arthroscopy. Front Surg. 2022 Aug 30;9:944481. doi: 10.3389/fsurg.2022.944481. eCollection 2022.

    PMID: 36111226BACKGROUND
  • Palmer W, Critchlow A, Mansingh A. Return to Sports and Functional Outcome after Primary Anterior Cruciate Ligament Reconstruction in Jamaica. Sports Nutrition and Therapy. 2016;1.

    BACKGROUND
  • van Montfoort DO, van Kampen PM, Huijsmans PE. Epinephrine Diluted Saline-Irrigation Fluid in Arthroscopic Shoulder Surgery: A Significant Improvement of Clarity of Visual Field and Shortening of Total Operation Time. A Randomized Controlled Trial. Arthroscopy. 2016 Mar;32(3):436-44. doi: 10.1016/j.arthro.2015.08.027.

    PMID: 26524933BACKGROUND
  • Biz C, Cigolotti A, Zonta F, Belluzzi E, Ruggieri P. ACL reconstruction using a bone patellar tendon bone (BPTB) allograft or a hamstring tendon autograft (GST): a single-center comparative study. Acta Biomed. 2019 Dec 5;90(12-S):109-117. doi: 10.23750/abm.v90i12-S.8973.

    PMID: 31821294BACKGROUND
  • Domnick C, Raschke MJ, Herbort M. Biomechanics of the anterior cruciate ligament: Physiology, rupture and reconstruction techniques. World J Orthop. 2016 Feb 18;7(2):82-93. doi: 10.5312/wjo.v7.i2.82. eCollection 2016 Feb 18.

    PMID: 26925379BACKGROUND
  • Gans I, Retzky JS, Jones LC, Tanaka MJ. Epidemiology of Recurrent Anterior Cruciate Ligament Injuries in National Collegiate Athletic Association Sports: The Injury Surveillance Program, 2004-2014. Orthop J Sports Med. 2018 Jun 13;6(6):2325967118777823. doi: 10.1177/2325967118777823. eCollection 2018 Jun.

    PMID: 29977938BACKGROUND
  • Wojtys EM, Brower AM. Anterior cruciate ligament injuries in the prepubescent and adolescent athlete: clinical and research considerations. J Athl Train. 2010 Sep-Oct;45(5):509-12. doi: 10.4085/1062-6050-45.5.509. No abstract available.

    PMID: 20831399BACKGROUND

MeSH Terms

Conditions

Anterior Cruciate Ligament Injuries

Interventions

Tourniquets

Condition Hierarchy (Ancestors)

Knee InjuriesLeg InjuriesWounds and Injuries

Intervention Hierarchy (Ancestors)

Equipment and Supplies

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Masking Details
All patients will be positioned supine and administered spinal anesthesia. In all cases the application of a pneumatic torniquet will be applied to the proximal thigh after induction of anesthesia but will not be inflated for the group receiving TXA. Dependent on the randomized groups assigned; The standard torniquet pressure of 300 mm Hg will only be inflated for persons assigned to the torniquet group who will receive normal saline intravenously. Only the research assistant and the anesthetic staff will be aware of whether inflation of torniquet was applied.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 19, 2024

First Posted

January 17, 2025

Study Start

November 1, 2024

Primary Completion

November 1, 2025

Study Completion

February 1, 2026

Last Updated

January 17, 2025

Record last verified: 2024-10

Locations